We are live on ! Find out more
TG

TRV GP Portfolio holdings

AUM $18.9M
1-Year Est. Return 541.67%
This Fund
S&P 500
This Quarter Est. Return
+94.44%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.78M
AUM Growth
-$38.8M
Cap. Flow
-$42.1M
Cap. Flow %
-621.32%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$42.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARM
1
DELISTED
Carisma Therapeutics
CARM
$6.78M 100%
242,080
– –
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-1,401,422
Closed -$42.1M

Similar funds

KA
KSL Advisors Denver, Colorado $16.1M AUM
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM
FFIM
Founders Fund II Management San Francisco, California $1.32M AUM
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

TRV GP's Q3 2020 Portfolio in Review

As of Q3 2020, TRV GP held 2 positions worth $6.78M, down 85% from $45.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP withdrew a net $42.1M in Q3 2020, closing 1 position. Its most notable exit was Constellation Pharmaceuticals, Inc., an estimated $42.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP fully exited Constellation Pharmaceuticals, Inc. in Q3 2020, selling an estimated $42.1M.
  • TRV GP's ten largest holdings make up 100% of its $6.78M portfolio in Q3 2020.
  • TRV GP opened 0 new positions and closed 1 in Q3 2020.
  • TRV GP's portfolio value fell 85% quarter-over-quarter to $6.78M.

Based on TRV GP's 13F filing for Q3 2020, filed 6 Nov 2020.